nodes	percent_of_prediction	percent_of_DWPC	metapath
Minaprine—ACHE—Alzheimer's disease	0.195	0.468	CbGaD
Minaprine—ACHE—Rivastigmine—Alzheimer's disease	0.144	0.306	CbGbCtD
Minaprine—ACHE—Donepezil—Alzheimer's disease	0.115	0.244	CbGbCtD
Minaprine—SLC6A4—Alzheimer's disease	0.0893	0.215	CbGaD
Minaprine—ACHE—Galantamine—Alzheimer's disease	0.0744	0.157	CbGbCtD
Minaprine—HTR2A—Alzheimer's disease	0.0687	0.165	CbGaD
Minaprine—CYP2D6—Alzheimer's disease	0.0628	0.151	CbGaD
Minaprine—HTR2A—Donepezil—Alzheimer's disease	0.05	0.106	CbGbCtD
Minaprine—DRD2—Memantine—Alzheimer's disease	0.0399	0.0845	CbGbCtD
Minaprine—CYP2D6—Rivastigmine—Alzheimer's disease	0.0208	0.044	CbGbCtD
Minaprine—CYP2D6—Donepezil—Alzheimer's disease	0.0166	0.0352	CbGbCtD
Minaprine—CYP2D6—Galantamine—Alzheimer's disease	0.0107	0.0227	CbGbCtD
Minaprine—HTR2C—choroid plexus—Alzheimer's disease	0.00842	0.166	CbGeAlD
Minaprine—HTR2A—choroid plexus—Alzheimer's disease	0.00422	0.0831	CbGeAlD
Minaprine—MAOA—locus ceruleus—Alzheimer's disease	0.004	0.0787	CbGeAlD
Minaprine—DRD1—telencephalic ventricle—Alzheimer's disease	0.00317	0.0625	CbGeAlD
Minaprine—HTR2A—locus ceruleus—Alzheimer's disease	0.00261	0.0513	CbGeAlD
Minaprine—HTR2C—telencephalic ventricle—Alzheimer's disease	0.00247	0.0485	CbGeAlD
Minaprine—HTR2A—cerebellar cortex—Alzheimer's disease	0.00213	0.0419	CbGeAlD
Minaprine—DRD2—telencephalic ventricle—Alzheimer's disease	0.00188	0.0369	CbGeAlD
Minaprine—HTR2A—telencephalic ventricle—Alzheimer's disease	0.00124	0.0243	CbGeAlD
Minaprine—Moclobemide—MAOB—Alzheimer's disease	0.00121	0.682	CrCbGaD
Minaprine—ACHE—telencephalon—Alzheimer's disease	0.000831	0.0164	CbGeAlD
Minaprine—DRD1—forebrain—Alzheimer's disease	0.000829	0.0163	CbGeAlD
Minaprine—DRD1—telencephalon—Alzheimer's disease	0.000762	0.015	CbGeAlD
Minaprine—HTR2C—forebrain—Alzheimer's disease	0.000644	0.0127	CbGeAlD
Minaprine—HTR2A—blood vessel—Alzheimer's disease	0.000612	0.0121	CbGeAlD
Minaprine—SLC6A4—forebrain—Alzheimer's disease	0.00061	0.012	CbGeAlD
Minaprine—CHRM1—forebrain—Alzheimer's disease	0.000608	0.012	CbGeAlD
Minaprine—HTR2B—forebrain—Alzheimer's disease	0.000605	0.0119	CbGeAlD
Minaprine—HTR2C—telencephalon—Alzheimer's disease	0.000592	0.0117	CbGeAlD
Minaprine—SLC6A4—telencephalon—Alzheimer's disease	0.000561	0.011	CbGeAlD
Minaprine—MAOA—embryo—Alzheimer's disease	0.00056	0.011	CbGeAlD
Minaprine—CHRM1—telencephalon—Alzheimer's disease	0.000559	0.011	CbGeAlD
Minaprine—HTR2B—telencephalon—Alzheimer's disease	0.000556	0.0109	CbGeAlD
Minaprine—MAOA—forebrain—Alzheimer's disease	0.000495	0.00975	CbGeAlD
Minaprine—DRD2—forebrain—Alzheimer's disease	0.00049	0.00964	CbGeAlD
Minaprine—ACHE—cerebellum—Alzheimer's disease	0.000462	0.00909	CbGeAlD
Minaprine—MAOA—telencephalon—Alzheimer's disease	0.000455	0.00896	CbGeAlD
Minaprine—DRD2—telencephalon—Alzheimer's disease	0.00045	0.00886	CbGeAlD
Minaprine—DRD1—nervous system—Alzheimer's disease	0.00045	0.00886	CbGeAlD
Minaprine—DRD1—central nervous system—Alzheimer's disease	0.000433	0.00853	CbGeAlD
Minaprine—Moclobemide—CYP2D6—Alzheimer's disease	0.000385	0.217	CrCbGaD
Minaprine—ACHE—brain—Alzheimer's disease	0.000375	0.00738	CbGeAlD
Minaprine—HTR2A—embryo—Alzheimer's disease	0.000365	0.00719	CbGeAlD
Minaprine—HTR2C—nervous system—Alzheimer's disease	0.00035	0.00688	CbGeAlD
Minaprine—DRD1—brain—Alzheimer's disease	0.000344	0.00677	CbGeAlD
Minaprine—HTR2C—central nervous system—Alzheimer's disease	0.000337	0.00662	CbGeAlD
Minaprine—SLC6A4—nervous system—Alzheimer's disease	0.000331	0.00652	CbGeAlD
Minaprine—CHRM1—nervous system—Alzheimer's disease	0.00033	0.0065	CbGeAlD
Minaprine—HTR2B—nervous system—Alzheimer's disease	0.000328	0.00646	CbGeAlD
Minaprine—HTR2A—forebrain—Alzheimer's disease	0.000323	0.00636	CbGeAlD
Minaprine—SLC6A4—central nervous system—Alzheimer's disease	0.000319	0.00628	CbGeAlD
Minaprine—CHRM1—central nervous system—Alzheimer's disease	0.000318	0.00626	CbGeAlD
Minaprine—HTR2B—central nervous system—Alzheimer's disease	0.000316	0.00622	CbGeAlD
Minaprine—HTR2A—telencephalon—Alzheimer's disease	0.000297	0.00585	CbGeAlD
Minaprine—CYP2D6—forebrain—Alzheimer's disease	0.000294	0.00579	CbGeAlD
Minaprine—CYP2D6—telencephalon—Alzheimer's disease	0.000271	0.00533	CbGeAlD
Minaprine—MAOA—nervous system—Alzheimer's disease	0.000269	0.00529	CbGeAlD
Minaprine—HTR2C—brain—Alzheimer's disease	0.000267	0.00526	CbGeAlD
Minaprine—DRD2—nervous system—Alzheimer's disease	0.000266	0.00523	CbGeAlD
Minaprine—MAOA—central nervous system—Alzheimer's disease	0.000259	0.00509	CbGeAlD
Minaprine—DRD2—central nervous system—Alzheimer's disease	0.000256	0.00504	CbGeAlD
Minaprine—SLC6A4—brain—Alzheimer's disease	0.000253	0.00499	CbGeAlD
Minaprine—MAOA—cerebellum—Alzheimer's disease	0.000253	0.00498	CbGeAlD
Minaprine—CHRM1—brain—Alzheimer's disease	0.000252	0.00497	CbGeAlD
Minaprine—HTR2B—brain—Alzheimer's disease	0.000251	0.00494	CbGeAlD
Minaprine—DRD2—cerebellum—Alzheimer's disease	0.00025	0.00492	CbGeAlD
Minaprine—MAOA—brain—Alzheimer's disease	0.000205	0.00404	CbGeAlD
Minaprine—DRD2—brain—Alzheimer's disease	0.000203	0.004	CbGeAlD
Minaprine—Gefitinib—CYP2D6—Alzheimer's disease	0.00018	0.101	CrCbGaD
Minaprine—HTR2A—nervous system—Alzheimer's disease	0.000175	0.00345	CbGeAlD
Minaprine—HTR2A—central nervous system—Alzheimer's disease	0.000169	0.00332	CbGeAlD
Minaprine—HTR2A—cerebellum—Alzheimer's disease	0.000165	0.00325	CbGeAlD
Minaprine—CYP2D6—nervous system—Alzheimer's disease	0.00016	0.00314	CbGeAlD
Minaprine—CYP2D6—central nervous system—Alzheimer's disease	0.000154	0.00303	CbGeAlD
Minaprine—CYP2D6—cerebellum—Alzheimer's disease	0.00015	0.00296	CbGeAlD
Minaprine—HTR2A—brain—Alzheimer's disease	0.000134	0.00264	CbGeAlD
Minaprine—CYP2D6—brain—Alzheimer's disease	0.000122	0.0024	CbGeAlD
Minaprine—CHRM1—Signaling Pathways—GAB2—Alzheimer's disease	6.12e-06	0.000103	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—NTRK2—Alzheimer's disease	6.12e-06	0.000103	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—GSK3A—Alzheimer's disease	6.1e-06	0.000103	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—CALM1—Alzheimer's disease	6.09e-06	0.000102	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—APP—Alzheimer's disease	6.09e-06	0.000102	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—MEF2C—Alzheimer's disease	6.09e-06	0.000102	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—NGFR—Alzheimer's disease	6.08e-06	0.000102	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—GSK3A—Alzheimer's disease	6.06e-06	0.000102	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—IGF1R—Alzheimer's disease	6.04e-06	0.000102	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—CREB1—Alzheimer's disease	6.04e-06	0.000102	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—MAOB—Alzheimer's disease	6.03e-06	0.000101	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—APP—Alzheimer's disease	5.99e-06	0.000101	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—PRKCG—Alzheimer's disease	5.97e-06	0.0001	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—APP—Alzheimer's disease	5.96e-06	0.0001	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—ADAM10—Alzheimer's disease	5.94e-06	9.98e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—CCL2—Alzheimer's disease	5.91e-06	9.94e-05	CbGpPWpGaD
Minaprine—MAOA—Metabolism—CALM1—Alzheimer's disease	5.89e-06	9.91e-05	CbGpPWpGaD
Minaprine—MAOA—Metabolism—APOE—Alzheimer's disease	5.87e-06	9.88e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—F2—Alzheimer's disease	5.85e-06	9.84e-05	CbGpPWpGaD
Minaprine—MAOA—Metabolism—CAV1—Alzheimer's disease	5.82e-06	9.79e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—NGF—Alzheimer's disease	5.82e-06	9.78e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	5.81e-06	9.77e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—LPL—Alzheimer's disease	5.79e-06	9.74e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—F2—Alzheimer's disease	5.76e-06	9.68e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PLCB1—Alzheimer's disease	5.75e-06	9.67e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—MEF2C—Alzheimer's disease	5.74e-06	9.65e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—F2—Alzheimer's disease	5.73e-06	9.63e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CCR5—Alzheimer's disease	5.66e-06	9.52e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PLCB1—Alzheimer's disease	5.66e-06	9.51e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—PRKCG—Alzheimer's disease	5.63e-06	9.47e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PLCB1—Alzheimer's disease	5.63e-06	9.46e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—S100B—Alzheimer's disease	5.61e-06	9.44e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—A2M—Alzheimer's disease	5.61e-06	9.43e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—HTR2A—Alzheimer's disease	5.54e-06	9.31e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—NGF—Alzheimer's disease	5.48e-06	9.22e-05	CbGpPWpGaD
Minaprine—ACHE—Metabolism—PPARG—Alzheimer's disease	5.43e-06	9.13e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—NGFR—Alzheimer's disease	5.36e-06	9.02e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—IGF2—Alzheimer's disease	5.34e-06	8.99e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CCR5—Alzheimer's disease	5.34e-06	8.97e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—CREB1—Alzheimer's disease	5.33e-06	8.96e-05	CbGpPWpGaD
Minaprine—ACHE—Metabolism—INS—Alzheimer's disease	5.32e-06	8.96e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—NGFR—Alzheimer's disease	5.28e-06	8.88e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—NGFR—Alzheimer's disease	5.25e-06	8.83e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—CREB1—Alzheimer's disease	5.24e-06	8.82e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—ADAM10—Alzheimer's disease	5.24e-06	8.81e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—HTR2A—Alzheimer's disease	5.22e-06	8.78e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—CREB1—Alzheimer's disease	5.22e-06	8.77e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—CCL2—Alzheimer's disease	5.21e-06	8.77e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—IGF1R—Alzheimer's disease	5.17e-06	8.69e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CALM1—Alzheimer's disease	5.17e-06	8.69e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—ADAM10—Alzheimer's disease	5.15e-06	8.67e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—LEP—Alzheimer's disease	5.15e-06	8.66e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—APOE—Alzheimer's disease	5.15e-06	8.66e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—CCL2—Alzheimer's disease	5.13e-06	8.63e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—ADAM10—Alzheimer's disease	5.13e-06	8.62e-05	CbGpPWpGaD
Minaprine—MAOA—Metabolism—PPARG—Alzheimer's disease	5.11e-06	8.6e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—CCL2—Alzheimer's disease	5.1e-06	8.58e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CAV1—Alzheimer's disease	5.1e-06	8.58e-05	CbGpPWpGaD
Minaprine—MAOA—Metabolism—INS—Alzheimer's disease	5.02e-06	8.44e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—LPL—Alzheimer's disease	4.95e-06	8.33e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—S100B—Alzheimer's disease	4.95e-06	8.33e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—ESR1—Alzheimer's disease	4.91e-06	8.27e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—MEF2C—Alzheimer's disease	4.91e-06	8.26e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—ACHE—Alzheimer's disease	4.88e-06	8.2e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—S100B—Alzheimer's disease	4.87e-06	8.2e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CALM1—Alzheimer's disease	4.87e-06	8.19e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—F2—Alzheimer's disease	4.85e-06	8.16e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—APOE—Alzheimer's disease	4.85e-06	8.16e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—LEP—Alzheimer's disease	4.85e-06	8.16e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—S100B—Alzheimer's disease	4.85e-06	8.15e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	4.82e-06	8.11e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—PRKCG—Alzheimer's disease	4.82e-06	8.1e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CAV1—Alzheimer's disease	4.81e-06	8.09e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—NOTCH1—Alzheimer's disease	4.75e-06	7.99e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—IGF2—Alzheimer's disease	4.72e-06	7.93e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—NGF—Alzheimer's disease	4.69e-06	7.89e-05	CbGpPWpGaD
Minaprine—ACHE—Metabolism—NOS3—Alzheimer's disease	4.67e-06	7.85e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—IGF2—Alzheimer's disease	4.64e-06	7.81e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—ESR1—Alzheimer's disease	4.63e-06	7.79e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—IGF2—Alzheimer's disease	4.62e-06	7.76e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—F2—Alzheimer's disease	4.58e-06	7.7e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	4.57e-06	7.69e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—ENO1—Alzheimer's disease	4.57e-06	7.69e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CCR5—Alzheimer's disease	4.56e-06	7.68e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—IGF1R—Alzheimer's disease	4.56e-06	7.67e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—IGF1R—Alzheimer's disease	4.49e-06	7.55e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—NOTCH1—Alzheimer's disease	4.48e-06	7.53e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—HTR2A—Alzheimer's disease	4.47e-06	7.51e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—IGF1R—Alzheimer's disease	4.46e-06	7.51e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—GSK3B—Alzheimer's disease	4.46e-06	7.5e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CREB1—Alzheimer's disease	4.42e-06	7.44e-05	CbGpPWpGaD
Minaprine—MAOA—Metabolism—NOS3—Alzheimer's disease	4.4e-06	7.4e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—INS—Alzheimer's disease	4.4e-06	7.4e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—LPL—Alzheimer's disease	4.37e-06	7.35e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—MEF2C—Alzheimer's disease	4.33e-06	7.29e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CCL2—Alzheimer's disease	4.33e-06	7.28e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—LPL—Alzheimer's disease	4.3e-06	7.24e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—LPL—Alzheimer's disease	4.28e-06	7.2e-05	CbGpPWpGaD
Minaprine—ACHE—Metabolism—PTGS2—Alzheimer's disease	4.27e-06	7.18e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—MEF2C—Alzheimer's disease	4.26e-06	7.17e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—IGF1—Alzheimer's disease	4.25e-06	7.15e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PRKCG—Alzheimer's disease	4.25e-06	7.15e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—BCHE—Alzheimer's disease	4.25e-06	7.15e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—MEF2C—Alzheimer's disease	4.24e-06	7.13e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—GSK3B—Alzheimer's disease	4.2e-06	7.07e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PRKCG—Alzheimer's disease	4.18e-06	7.04e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CREB1—Alzheimer's disease	4.17e-06	7.01e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CALM1—Alzheimer's disease	4.17e-06	7.01e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PRKCG—Alzheimer's disease	4.16e-06	7e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—APOE—Alzheimer's disease	4.15e-06	6.98e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—LEP—Alzheimer's disease	4.15e-06	6.98e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—INS—Alzheimer's disease	4.15e-06	6.97e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—NGF—Alzheimer's disease	4.14e-06	6.96e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CAV1—Alzheimer's disease	4.11e-06	6.92e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CCL2—Alzheimer's disease	4.08e-06	6.86e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—NGF—Alzheimer's disease	4.07e-06	6.85e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—NGF—Alzheimer's disease	4.05e-06	6.82e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CCR5—Alzheimer's disease	4.03e-06	6.78e-05	CbGpPWpGaD
Minaprine—MAOA—Metabolism—PTGS2—Alzheimer's disease	4.02e-06	6.77e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—IGF1—Alzheimer's disease	4.01e-06	6.75e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	4.01e-06	6.74e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—ESR1—Alzheimer's disease	3.96e-06	6.67e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CCR5—Alzheimer's disease	3.96e-06	6.67e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CCR5—Alzheimer's disease	3.94e-06	6.63e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—HTR2A—Alzheimer's disease	3.94e-06	6.63e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—F2—Alzheimer's disease	3.92e-06	6.59e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	3.89e-06	6.54e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—HTR2A—Alzheimer's disease	3.86e-06	6.49e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—NOS3—Alzheimer's disease	3.86e-06	6.49e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—NOTCH1—Alzheimer's disease	3.83e-06	6.45e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CALM1—Alzheimer's disease	3.68e-06	6.19e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—APOE—Alzheimer's disease	3.66e-06	6.16e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—LEP—Alzheimer's disease	3.66e-06	6.16e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—NOS3—Alzheimer's disease	3.64e-06	6.12e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CAV1—Alzheimer's disease	3.63e-06	6.11e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CALM1—Alzheimer's disease	3.62e-06	6.09e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—LEP—Alzheimer's disease	3.61e-06	6.07e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—APOE—Alzheimer's disease	3.61e-06	6.07e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CALM1—Alzheimer's disease	3.6e-06	6.05e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—GSK3B—Alzheimer's disease	3.6e-06	6.05e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—LEP—Alzheimer's disease	3.59e-06	6.03e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—APOE—Alzheimer's disease	3.59e-06	6.03e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CAV1—Alzheimer's disease	3.57e-06	6.01e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CREB1—Alzheimer's disease	3.57e-06	6e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CAV1—Alzheimer's disease	3.55e-06	5.98e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—INS—Alzheimer's disease	3.55e-06	5.97e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—ESR1—Alzheimer's disease	3.5e-06	5.88e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CCL2—Alzheimer's disease	3.49e-06	5.87e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—F2—Alzheimer's disease	3.46e-06	5.81e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—ESR1—Alzheimer's disease	3.44e-06	5.79e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—IGF1—Alzheimer's disease	3.43e-06	5.77e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—ESR1—Alzheimer's disease	3.42e-06	5.76e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—F2—Alzheimer's disease	3.4e-06	5.72e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—F2—Alzheimer's disease	3.38e-06	5.69e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—NOTCH1—Alzheimer's disease	3.38e-06	5.69e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	3.35e-06	5.63e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	3.33e-06	5.61e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—NOTCH1—Alzheimer's disease	3.33e-06	5.6e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—NOTCH1—Alzheimer's disease	3.31e-06	5.57e-05	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—AKT1—Alzheimer's disease	3.3e-06	5.56e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CASP3—Alzheimer's disease	3.27e-06	5.51e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—IL6—Alzheimer's disease	3.25e-06	5.47e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—GSK3B—Alzheimer's disease	3.17e-06	5.34e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CREB1—Alzheimer's disease	3.15e-06	5.3e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—INS—Alzheimer's disease	3.13e-06	5.27e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—GSK3B—Alzheimer's disease	3.12e-06	5.25e-05	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—AKT1—Alzheimer's disease	3.12e-06	5.24e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—NOS3—Alzheimer's disease	3.11e-06	5.23e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—GSK3B—Alzheimer's disease	3.11e-06	5.22e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CREB1—Alzheimer's disease	3.1e-06	5.21e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CASP3—Alzheimer's disease	3.09e-06	5.19e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CREB1—Alzheimer's disease	3.08e-06	5.18e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—INS—Alzheimer's disease	3.08e-06	5.18e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CCL2—Alzheimer's disease	3.08e-06	5.18e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—IL6—Alzheimer's disease	3.07e-06	5.16e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—INS—Alzheimer's disease	3.06e-06	5.15e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—LPL—Alzheimer's disease	3.05e-06	5.13e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CCL2—Alzheimer's disease	3.03e-06	5.1e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—IGF1—Alzheimer's disease	3.03e-06	5.09e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CCL2—Alzheimer's disease	3.01e-06	5.07e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—MAPK8—Alzheimer's disease	3.01e-06	5.06e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—AKT1—Alzheimer's disease	3e-06	5.05e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—IGF1—Alzheimer's disease	2.98e-06	5.01e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—IGF1—Alzheimer's disease	2.96e-06	4.98e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—MAPK8—Alzheimer's disease	2.84e-06	4.77e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—AKT1—Alzheimer's disease	2.83e-06	4.76e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—VEGFA—Alzheimer's disease	2.78e-06	4.67e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	2.75e-06	4.62e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—NOS3—Alzheimer's disease	2.75e-06	4.62e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—NOS3—Alzheimer's disease	2.7e-06	4.54e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—NOS3—Alzheimer's disease	2.69e-06	4.52e-05	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—AKT1—Alzheimer's disease	2.67e-06	4.48e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CASP3—Alzheimer's disease	2.64e-06	4.44e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—IL6—Alzheimer's disease	2.62e-06	4.41e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—VEGFA—Alzheimer's disease	2.62e-06	4.41e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—CALM1—Alzheimer's disease	2.57e-06	4.32e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—APOE—Alzheimer's disease	2.56e-06	4.3e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—TGFB1—Alzheimer's disease	2.55e-06	4.29e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—CAV1—Alzheimer's disease	2.53e-06	4.26e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—MAPK8—Alzheimer's disease	2.43e-06	4.08e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—AKT1—Alzheimer's disease	2.42e-06	4.07e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—TGFB1—Alzheimer's disease	2.4e-06	4.04e-05	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—AKT1—Alzheimer's disease	2.35e-06	3.96e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CASP3—Alzheimer's disease	2.33e-06	3.92e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—IL6—Alzheimer's disease	2.32e-06	3.9e-05	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—AKT1—Alzheimer's disease	2.31e-06	3.89e-05	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	2.3e-06	3.87e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CASP3—Alzheimer's disease	2.29e-06	3.86e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CASP3—Alzheimer's disease	2.28e-06	3.84e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—IL6—Alzheimer's disease	2.28e-06	3.83e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—IL6—Alzheimer's disease	2.27e-06	3.81e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—VEGFA—Alzheimer's disease	2.24e-06	3.77e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PPARG—Alzheimer's disease	2.23e-06	3.75e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—INS—Alzheimer's disease	2.18e-06	3.67e-05	CbGpPWpGaD
Minaprine—ACHE—Metabolism—AKT1—Alzheimer's disease	2.15e-06	3.61e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—MAPK8—Alzheimer's disease	2.14e-06	3.6e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—AKT1—Alzheimer's disease	2.14e-06	3.59e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—MAPK8—Alzheimer's disease	2.11e-06	3.55e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—AKT1—Alzheimer's disease	2.1e-06	3.54e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—TP53—Alzheimer's disease	2.1e-06	3.53e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—MAPK8—Alzheimer's disease	2.1e-06	3.53e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—AKT1—Alzheimer's disease	2.09e-06	3.52e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—TGFB1—Alzheimer's disease	2.06e-06	3.46e-05	CbGpPWpGaD
Minaprine—MAOA—Metabolism—AKT1—Alzheimer's disease	2.02e-06	3.4e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—TP53—Alzheimer's disease	1.98e-06	3.33e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—VEGFA—Alzheimer's disease	1.98e-06	3.33e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.95e-06	3.27e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—VEGFA—Alzheimer's disease	1.94e-06	3.26e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—IL6—Alzheimer's disease	1.92e-06	3.23e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—NOS3—Alzheimer's disease	1.92e-06	3.22e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—TGFB1—Alzheimer's disease	1.82e-06	3.05e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—IL6—Alzheimer's disease	1.81e-06	3.05e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.79e-06	3e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—TGFB1—Alzheimer's disease	1.78e-06	2.99e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—AKT1—Alzheimer's disease	1.77e-06	2.98e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	1.75e-06	2.95e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—TP53—Alzheimer's disease	1.69e-06	2.85e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—AKT1—Alzheimer's disease	1.67e-06	2.81e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—IL6—Alzheimer's disease	1.55e-06	2.61e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—TP53—Alzheimer's disease	1.49e-06	2.51e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—TP53—Alzheimer's disease	1.47e-06	2.47e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—TP53—Alzheimer's disease	1.46e-06	2.46e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—AKT1—Alzheimer's disease	1.43e-06	2.41e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—IL6—Alzheimer's disease	1.37e-06	2.3e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—IL6—Alzheimer's disease	1.35e-06	2.26e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—IL6—Alzheimer's disease	1.34e-06	2.25e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—AKT1—Alzheimer's disease	1.26e-06	2.12e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—AKT1—Alzheimer's disease	1.24e-06	2.09e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—AKT1—Alzheimer's disease	1.24e-06	2.08e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—AKT1—Alzheimer's disease	8.8e-07	1.48e-05	CbGpPWpGaD
